Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xcess Biosciences
Chicago, Illinois, United Statesxcessbio.com ↗
- Ownership
- Private
- Employees
- ~30
- Development stage
- Other
01
Overview
Xcess Biosciences specializes in custom synthesis of small molecules, lead optimization, and supplies chemical reagents such as the GSK3β inhibitor CHIR99021 that are widely used in stem cell and Wnt pathway research, with proven capability in both medicinal and process chemistry for pharma and biotech clients
- Therapeutic areas
- HematologyNeurologyOther
- Modalities
- Small molecule
- Industry
- Drug Discovery Services
02
Partnerships
Cedarlane (distribution and manufacturing partner)Cosmo Bio Co., Ltd (distribution)
Beyond the preview
Go deeper on Xcess Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xcess Biosciences.